Overview
Growth hormone deficiency (GHD) refers to insufficient production of growth hormone by the pituitary gland, leading to impaired growth in children and various metabolic issues in both children and adults 210.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Wright CM, Chapman S, Cole TJ. How can we best chart children's growth in the paperless age? The UK experience. Archives of disease in childhood 2024. link 2 Attia N, Moussa K, Altwaim A, Al-Agha AE, Amir AA, Almuhareb A. Tackling access and payer barriers for growth hormone therapy in Saudi Arabia: a consensus statement for the Saudi Working Group for Pediatric Endocrinology. Journal of pediatric endocrinology & metabolism : JPEM 2024. link 3 Marin M, Murru FM, Baldo F, Tamaro G, Faleschini E, Barbi E et al.. Minimizing unnecessary brain magnetic resonance imaging in pediatric endocrinology: a retrospective cohort analysis. Frontiers in endocrinology 2024. link 4 Middelkoop K, Micklesfield L, Stewart J, Walker N, Jolliffe DA, Mendham AE et al.. Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids). BMJ paediatrics open 2024. link 5 Aytaç Kaplan EH, Kocabey Sütçü Z, Soyaltın E, Onal H. Ambulatory blood pressure monitorisation in children with recombinant growth hormone treatment. Journal of pediatric endocrinology & metabolism : JPEM 2024. link 6 Abdelazeem AS, Fayed AMA, Basyony MM, Abu Hafsa SH, Mahmoud AEM. Hematology profile, digestive enzymes, thyroid hormones, productivity, and nitrogen balance of growing male rabbits supplemented with exogenous dietary lysozyme. Animal biotechnology 2023. link 7 Abe I, Takeshita K, Nagata M, Fujita Y, Ochi K, Koga M et al.. Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study. Medicine 2023. link 8 Kuba VM, Castro ABS, Leone C, Damiani D. Osteometabolic profile and bone mass in the transition phase: ethnic differences in Brazilians treated with somatropin during childhood. Jornal de pediatria 2023. link 9 Aguiar-Oliveira MH, Salvatori R. The state of Sergipe contribution to GH research: from Souza Leite to Itabaianinha syndrome. Archives of endocrinology and metabolism 2022. link 10 Wang P, Jin X, Zhang Y, Zhang J, Li Y, Yang S et al.. Effect of Vitamin D Combined with Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency. Disease markers 2022. link 11 Almaghraby A, Jaju A, Ryan ME, Rychlik K, Habiby RL, Brickman WJ. Is Gadolinium Contrast Necessary for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?. Hormone research in paediatrics 2021. link 12 Yuen KCJ, Alter CA, Miller BS, Gannon AW, Tritos NA, Samson SL et al.. Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2021. link 13 Hu YH, Wang XY, Yao HY, Zhang J, Yin DP, Feng Guo S. Increases in Height among Chinese Children and Adolescents by Gender: An Age-Period-Cohort Analysis. Biomedical and environmental sciences : BES 2021. link 14 Ma K, Wei SQ, Bi WG, Weiler HA, Wen SW. Effect of Vitamin D Supplementation in Early Life on Children's Growth and Body Composition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2021. link 15 Kuramochi E, Mae K, Ohtomo Y, Kamada R, Sugano-Tajima H, Asano T. Growth Hormone Treatment at Nippon Medical School Chiba Hokusoh Hospital. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2021. link 16 Boguszewski CL, Boguszewski MCDS, de Herder WW. From dwarves to giants: South American's contribution to the history of growth hormone and related disorders. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2020. link 17 Garcia Rincon LJ, Alencar GP, Cardoso MA, Narvai PC, Frazão P. Effect of birth weight and nutritional status on transverse maxillary growth: Implications for maternal and infant health. PloS one 2020. link 18 de Andrade BMR, Valença EHO, Salvatori R, Souza AHO, Oliveira-Neto LA, Oliveira AHA et al.. Effects of Therapy With Semi-occluded Vocal Tract and Choir Training on Voice in Adult Individuals With Congenital, Isolated, Untreated Growth Hormone Deficiency. Journal of voice : official journal of the Voice Foundation 2019. link 19 Lewiński A, Smyczyńska J, Stawerska R, Hilczer M, Stasiak M, Bednarczuk T et al.. National Program of Severe Growth Hormone Deficiency Treatment in Adults and Adolescents after Completion of Growth Promoting Therapy. Endokrynologia Polska 2018. link 20 Pfäffle R, Land C, Schönau E, Holterhus PM, Ross JL, Piras de Oliveira C et al.. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS). Hormone research in paediatrics 2018. link 21 Rodrigues-Neto AJ, Biazoni-Albaricci C, Ribeiro A, Lima S, Figueras A. Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes. European journal of clinical pharmacology 2018. link 22 Ozono K, Ogata T, Horikawa R, Matsubara Y, Ogawa Y, Nishijima K et al.. Efficacy and safety of two doses of Norditropin. Endocrine journal 2018. link 23 Callahan SR, Cross AJ, DeDecker AE, Lindemann MD, Estienne MJ. Effects of group-size-floor space allowance during the nursery phase of production on growth, physiology, and hematology in replacement gilts. Journal of animal science 2017. link 24 Collin J, Whitehead A, Walker J. Educating children and families about growth hormone deficiency and its management: part 2. Nursing children and young people 2016. link 25 Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P et al.. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. European journal of endocrinology 2016. link 26 Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016. link 27 Lazure P, Bartel RC, Biller BM, Molitch ME, Rosenthal SM, Ross JL et al.. Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology. BMC health services research 2014. link 28 Souza AH, Farias MI, Salvatori R, Silva GM, Santana JA, Pereira FA et al.. Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification. Endocrine 2014. link 29 Rotwein P. William H. Daughaday and the foundations of modern research into growth hormone and the insulin-like growth factors. Pediatric endocrinology reviews : PER 2013. link 30 Shalet SM. Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist. European journal of endocrinology 2013. link 31 Ameri P, Giusti A, Boschetti M, Bovio M, Teti C, Leoncini G et al.. Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. European journal of endocrinology 2013. link 32 García RJ, Martinez-Aguayo A, Mericq V. How to optimally manage growth hormone therapy: survey of Chilean pediatric endocrinologists. Hormone research in paediatrics 2012. link 33 Laron Z. Growth hormone therapy: emerging dilemmas. Pediatric endocrinology reviews : PER 2011. link 34 Cho H, Daniel T, Buechler YJ, Litzinger DC, Maio Z, Putnam AM et al.. Optimized clinical performance of growth hormone with an expanded genetic code. Proceedings of the National Academy of Sciences of the United States of America 2011. link 35 Sönksen P. The International Olympic Committee (IOC) and GH-2000. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2009. link 36 Louvel M, Marcu M, Trivin C, Souberbielle JC, Brauner R. Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency. BMC pediatrics 2009. link 37 Whatmore AJ, Patel L, Clayton PE. A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment. Clinical endocrinology 2009. link 38 Plengpanich W, Mangkala J, Buranasukajorn P, Boonruang K, Sunthornyothin S, Suwanwalaikorn S et al.. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2008. link 39 Bidlingmaier M, Strasburger CJ. What endocrinologists should know about growth hormone measurements. Endocrinology and metabolism clinics of North America 2007. link 40 Nindl BC. Exercise modulation of growth hormone isoforms: current knowledge and future directions for the exercise endocrinologist. British journal of sports medicine 2007. link 41 Buzzini SR. Abuse of growth hormone among young athletes. Pediatric clinics of North America 2007. link 42 Daughaday WH. Endocrinology--the way we were: a personal history of somatomedin. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2006. link 43 Ur E, Serri O, Legg K, Murphy LJ, Ezzat S. Canadian guidelines for the management of adult growth hormone deficiency. Clinical and investigative medicine. Medecine clinique et experimentale 2006. link 44 Kirk J, Clayton P. Specialist services and transitional care in paediatric endocrinology in the UK and Ireland. Clinical endocrinology 2006. link 45 Hilczer M, Smyczynska J, Stawerska R, Lewinski A. Stability of IGF-I concentration despite divergent results of repeated GH stimulating tests indicates poor reproducibility of test results. Endocrine regulations 2006. link 46 Rosenbloom AL, Guevara-Aguirre J. Controversy in clinical endocrinology: reclassification of insulin-like growth factor I production and action disorders. The Journal of clinical endocrinology and metabolism 2006. link 47 Federico G, Street ME, Maghnie M, Caruso-Nicoletti M, Loche S, Bertelloni S et al.. Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED). Journal of endocrinological investigation 2006. link 48 Farber RS, Kerrigan JR. The multiple indications for growth hormone treatment of pediatric patients. Pediatric annals 2006. link 49 Cuttler L, Silvers JB, Singh J, Tsai AC, Radcliffe D. Physician decisions to discontinue long-term medications using a two-stage framework: the case of growth hormone therapy. Medical care 2005. link 50 Albero R, Trincado P, Sanz A, Playán J, Acha J. Child-onset growth hormone deficiency in adulthood. Transfer of patients from pediatric to adult endocrinology units. Journal of pediatric endocrinology & metabolism : JPEM 2004. link 51 Pugeat M. Advances in growth hormone therapy: a new registry tool. Hormone research 2004. link 52 Rai A, Reddy HR. Evaluation of dietary essentiality of vitamins for Penaeus monodon (Fabricius). Indian journal of experimental biology 2004. link 53 Irie M, Itoh Y, Miyashita Y, Tsushima T, Shirai K. Complications in adults with growth hormone deficiency--a survey study in Japan. Endocrine journal 2004. link 54 Lyon M, Deakin JA, Lietha D, Gherardi E, Gallagher JT. The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides. The Journal of biological chemistry 2004. link 55 Janssen JA, van der Lely AJ, Lamberts SW. Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity. Journal of endocrinological investigation 2003. link 56 Pantel J, Grulich-Henn J, Bettendorf M, Strasburger CJ, Heinrich U, Amselem S. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. The Journal of clinical endocrinology and metabolism 2003. link 57 Matich J, Basford Nicholson LF, Barling PM. Mitotic activity in the growing red deer antler. Cell biology international 2003. link00118-5) 58 Falcón J, Besseau L, Fazzari D, Attia J, Gaildrat P, Beauchaud M et al.. Melatonin modulates secretion of growth hormone and prolactin by trout pituitary glands and cells in culture. Endocrinology 2003. link 59 Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency. The Journal of clinical endocrinology and metabolism 2002. link 60 Lee KW, Cohen P. Individualizing growth hormone dosing in children. Hormone research 2001. link 61 Strasburger CJ, Bidlingmaier M, Wu Z, Morrison KM. Normal values of insulin-like growth factor I and their clinical utility in adults. Hormone research 2001. link 62 Jørgensen JO, Hansen TK, Conceição FL, Christensen JJ, Vahl N, Christiansen JS. Short-term tools to measure responsiveness to growth hormone replacement. Hormone research 2001. link 63 Galasso C, Scirè G, Fabbri F, Spadoni GL, Killoran CE, Biesecker LG et al.. Long-term treatment with growth hormone improves final height in a patient with Pallister-Hall syndrome. American journal of medical genetics 2001. link9999:9999<::aid-ajmg1128>3.0.co;2-s) 64 Muller AF, Leebeek FW, Janssen JA, Lamberts SW, Hofland L, van der Lely AJ. Acute effect of pegvisomant on cardiovascular risk markers in healthy men: implications for the pathogenesis of atherosclerosis in GH deficiency. The Journal of clinical endocrinology and metabolism 2001. link 65 Al-Herbish AS, Al-Jurayyan NA, Abobakr AM, Al-Nuaim AA. Growth hormone: do we have a national perspective of indications for its use?. Saudi medical journal 2000. link 66 Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M et al.. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. European journal of endocrinology 2000. link 67 Owens GM. Clinician and payer issues in managing growth hormone deficiency. The American journal of managed care 2000. link 68 Nelson WW, Frear RS. Physician attitudes toward human growth hormone products. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999. link 69 Maheshwari HG, Silverman BL, Dupuis J, Baumann G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. The Journal of clinical endocrinology and metabolism 1998. link 70 Frohman LA. New insights into the regulation of somatotrope function using genetic and transgenic models. Metabolism: clinical and experimental 1996. link90067-0) 71 Hirano T, Izumi I, Tamura K. Growth hormone deficiency in Dubowitz syndrome. Acta paediatrica Japonica : Overseas edition 1996. link 72 Zou H, Zhang Y, Lu P, Krull IS. Characterization of immunochemical reaction for human growth hormone with its monoclonal antibody by perfusion protein G affinity chromatography and capillary zone electrophoresis. Biomedical chromatography : BMC 1996. link1099-0801(199603)10:2<78::AID-BMC556>3.0.CO;2-D) 73 Allen DB. Safety of human growth hormone therapy: current topics. The Journal of pediatrics 1996. link70003-3) 74 Hassan HM, Kohno H, Kuromaru R, Honda S, Ueda K. Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment. Acta paediatrica (Oslo, Norway : 1992) 1996. link 75 Carlsson LM. Partial growth hormone insensitivity in childhood. Bailliere's clinical endocrinology and metabolism 1996. link80515-5) 76 Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. The Journal of clinical endocrinology and metabolism 1995. link 77 . Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. The Journal of pediatrics 1995. link70019-6) 78 Mohan S, Baylink DJ. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. The Journal of clinical endocrinology and metabolism 1995. link 79 Upton Z, Francis GL, Kita K, Wallace JC, Ballard FJ. Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli. Journal of molecular endocrinology 1995. link 80 Murphy LJ, Molnar P, Lu X, Huang H. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. Journal of molecular endocrinology 1995. link 81 Laron Z, Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Hormone research 1994. link 82 Chipman JJ. Recent advances in hGH clinical research. The Journal of pediatric endocrinology 1993. link 83 Cardoso AI, Llera AS, Iacono RF, Domené HM, Martínez AS, Heinrich JJ et al.. Heterologous humoral immune response in patients treated with human growth hormone from different sources. Acta endocrinologica 1993. link 84 Rosén T, Edén S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta endocrinologica 1993. link 85 Tetel MJ, Blaustein JD. Immunocytochemical evidence for noradrenergic regulation of estrogen receptor concentrations in the guinea pig hypothalamus. Brain research 1991. link91664-m) 86 Martin NA, Macagba-Crain CL, Geffner M, Peacock W. Isolated growth hormone deficiency associated with a giant arteriovenous varix. Neurosurgery 1990. link 87 Saartok T, Häggmark T. Human growth hormone: friend or foe in sports medicine?. Bulletin of the Hospital for Joint Diseases Orthopaedic Institute 1988. link 88 Horváth S, Palkovits M. Synaptic interconnections among growth hormone-releasing hormone (GHRH)-containing neurons in the arcuate nucleus of the rat hypothalamus. Neuroendocrinology 1988. link 89 Chomczynski P, Downs TR, Frohman LA. Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. Molecular endocrinology (Baltimore, Md.) 1988. link 90 Harvey S, Hoshino S, Suzuki M. Plasma immunoreactive-growth hormone in domestic fowl: measurement by homologous and heterologous radioimmunoassays. General and comparative endocrinology 1987. link90227-9) 91 Girard J, Erb T, Pampalone A, Eberle AN, Baumann JB. Growth hormone in urine: development of an ultrasensitive assay applicable to plasma and urine. Hormone research 1987. link 92 VandePol CJ, Leidy JW, Finger TE, Robbins RJ. Immunohistochemical localization of GRF-containing neurons in rat brain. Neuroendocrinology 1986. link 93 Ueda H, Kagawa H, Fujimoto S. Immunoelectron microscopic localization of growth hormone in the pituitary glands of two teleosts, tilapia (Sarotherodon mossambicus) and amago salmon (Oncorhynchus rhodurus). General and comparative endocrinology 1985. link90429-0) 94 Pan JX, Lechan RM, Lin HD, Sohn J, Reichlin S, Jackson IM. Multiple forms of human pancreatic growth hormone releasing factor-like immunoreactivity in teleost brain and pituitary. Endocrinology 1985. link 95 Sawchenko PE, Swanson LW, Rivier J, Vale WW. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. The Journal of comparative neurology 1985. link 96 Merchenthaler I, Thomas CR, Arimura A. Immunocytochemical localization of growth hormone releasing factor (GHRF)-containing structures in the rat brain using anti-rat GHRF serum. Peptides 1984. link90173-6) 97 Esch F, Böhlen P, Ling N, Brazeau P, Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochemical and biophysical research communications 1983. link91664-9) 98 Stephenson FA, Bornstein J. Human urinary insulin-potentiating peptide: immunological evidence for the absence of the human growth hormone amino terminal sequence, Phe-Pro-Thr-Ile-Pro-. Molecular and cellular endocrinology 1981. link90069-1) 99 Pelletier G, Leclerc R, Dube D, Labrie F, Puviani R, Arimura A et al.. Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brain. The American journal of anatomy 1975. link 100 Drummond T. Immunohistochemical detection of changes in growth hormone cells in rat pituitaries in protein deficiency. The British journal of nutrition 1975. link